References checked

References

• mehra2020 · Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis · 10.1016/s0140-6736(20)31180-6

  Retracted This paper has been retracted. Remove it, or cite it as retracted. Retraction notice
  Expression of concern The journal has published an expression of concern about this paper: check that you can still rely on it. Notice
  Correction published A correction to this paper has been published: check that it does not change what you cite. Correction

• wakefield1998 · Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children · 10.1016/s0140-6736(97)11096-0

  Retracted This paper has been retracted. Remove it, or cite it as retracted. Retraction notice
  Correction published A correction to this paper has been published: check that it does not change what you cite. Correction
  Incomplete entry Added from the record that identifies it: doi = 10.1016/s0140-6736(97)11096-0.
  Suggested corrected entry — review before using

  Your entry

  @article{wakefield1998,
    title={Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children},
    author={Wakefield, A. J. and Murch, S. H. and Anthony, A. and others},
    journal={The Lancet},
    volume={351},
    pages={637--641},
    year={1998}
  }

  Corrected

  @article{wakefield1998,
    title = {Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children},
    author = {Wakefield, A. J. and Murch, S. H. and Anthony, A. and others},
    journal = {The Lancet},
    volume = {351},
    pages = {637--641},
    year = {1998},
    doi = {10.1016/s0140-6736(97)11096-0},
  }

  Keep this correction in the downloaded .bib

• routy2018 · Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors · 10.1126/science.aan3706

  Correction published A correction to this paper has been published: check that it does not change what you cite. Correction
  Reference to correct Record found in Crossref

  • Year : 2017 → 2018
  Suggested corrected entry — review before using

  Your entry

  @article{routy2018,
    title={Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors},
    author={Routy, Bertrand and Le Chatelier, Emmanuelle and Derosa, Lisa and others},
    journal={Science},
    volume={359},
    pages={91--97},
    year={2017}
  }

  Corrected

  @article{routy2018,
    title = {Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors},
    author = {Routy, Bertrand and Le Chatelier, Emmanuelle and Derosa, Lisa and others},
    journal = {Science},
    volume = {359},
    pages = {91--97},
    year = {2018},
    doi = {10.1126/science.aan3706},
  }

  Keep this correction in the downloaded .bib

• gopalakrishnan2018b · Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients · 10.1126/science.aan4236

  Duplicate The same paper as gopalakrishnan2018.
  Incomplete entry Added from the record that identifies it: doi = 10.1126/science.aan4236.
  Suggested corrected entry — review before using

  Your entry

  @article{gopalakrishnan2018b,
    title={Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients},
    author={Gopalakrishnan, Vancheswaran and Spencer, Christine N. and Nezi, Luigi and others},
    journal={Science},
    volume={359},
    pages={97--103},
    year={2018}
  }

  Corrected

  @article{gopalakrishnan2018b,
    title = {Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients},
    author = {Gopalakrishnan, Vancheswaran and Spencer, Christine N. and Nezi, Luigi and others},
    journal = {Science},
    volume = {359},
    pages = {97--103},
    year = {2018},
    doi = {10.1126/science.aan4236},
  }

  Keep this correction in the downloaded .bib

• gopalakrishnan2018 · Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients · 10.1126/science.aan4236

  Incomplete entry Added from the record that identifies it: doi = 10.1126/science.aan4236, volume = 359, pages = 97-103.
  Suggested corrected entry — review before using

  Your entry

  @article{gopalakrishnan2018,
    title={Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients},
    author={Gopalakrishnan, V. and Spencer, C. N. and Nezi, L. and others},
    journal={Science},
    year={2018}
  }

  Corrected

  @article{gopalakrishnan2018,
    title = {Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients},
    author = {Gopalakrishnan, V. and Spencer, C. N. and Nezi, L. and others},
    journal = {Science},
    year = {2018},
    doi = {10.1126/science.aan4236},
    volume = {359},
    pages = {97-103},
  }

  Keep this correction in the downloaded .bib

• sivan2015 · Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy · 10.1126/science.aac4255

  Incomplete entry Added from the record that identifies it: doi = 10.1126/science.aac4255, volume = 350, pages = 1084-1089, journal = Science.
  Suggested corrected entry — review before using

  Your entry

  @article{sivan2015,
    title={Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy},
    author={Sivan, Ayelet and Corrales, Leticia and Hubert, Nathaniel and others},
    year={2015}
  }

  Corrected

  @article{sivan2015,
    title = {Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy},
    author = {Sivan, Ayelet and Corrales, Leticia and Hubert, Nathaniel and others},
    year = {2015},
    doi = {10.1126/science.aac4255},
    volume = {350},
    pages = {1084-1089},
    journal = {Science},
  }

  Keep this correction in the downloaded .bib

Citations to check

2 sentences with citations read out of 4: those that attribute a result, a value or a method to a paper first. Each sentence is read with the abstracts of all the papers it cites; those flagged are read again against the full text of the papers when it may be read. A flagged citation may be right: check it in the paper. Full texts read: 0 of the 4 papers concerned (the others are closed to text mining or could not be fetched).

• The abstract says otherwise cited for a result · main.tex, line 6

  Routy et al. showed that antibiotic treatment improved the response of patients with epithelial tumours to PD-1 blockade [routy2018].

  The abstract associates antibiotic consumption with a poor response to PD-1 blockade, not an improved response.

  routy2018 · Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

  Abstract

  Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila . Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science , this issue p. 91 , p. 104 , p. 97 ; see also p. 32

• Not in the abstract cited for a result · main.tex, line 7

  Commensal Bifidobacterium promotes antitumour immunity in mice [sivan2015], and responders carry a more diverse gut microbiome [gopalakrishnan2018, gopalakrishnan2018b].

  Although Sivan supports the antitumour effect of Bifidobacterium in mice, the Gopalakrishnan abstracts describe bacterial abundance and composition without stating that responders have greater gut microbiome diversity.

  gopalakrishnan2018 · Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

  Abstract

  Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila . Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science , this issue p. 91 , p. 104 , p. 97 ; see also p. 32

  gopalakrishnan2018b · Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

  Abstract

  Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blockade. They profiled samples from patients with lung and kidney cancers and found that nonresponding patients had low levels of the bacterium Akkermansia muciniphila . Oral supplementation of the bacteria to antibiotic-treated mice restored the response to immunotherapy. Matson et al. and Gopalakrishnan et al. studied melanoma patients receiving PD-1 blockade and found a greater abundance of “good” bacteria in the guts of responding patients. Nonresponders had an imbalance in gut flora composition, which correlated with impaired immune cell activity. Thus, maintaining healthy gut flora could help patients combat cancer. Science , this issue p. 91 , p. 104 , p. 97 ; see also p. 32